4th Quarter - Report
BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
Client
Income
—
Expenses
$580,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to device cybersecurity
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017 H.R.1, Tax Cuts and Jobs Act, Issues related to corporate tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Health Issues HCR
Issues related to antimicrobial resistance Clinical lab fee schedule H.R.2430, FDA Reauthorization Act of 2017 VA procurement Issues related to hazardous drug safety Issues related to medical technology regulation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Budget/Appropriations BUD
NIH Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY | — |
| TODD SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.